MeƱoza, Ann-jelly .
HRN: 23-75-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
AMPICILLIN 1GM (VIAL)
09/29/2023
10/06/2023
IV
2gm
Q6
PROM X 8 Hours
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes